Berry Global Healthcare has announced its attendance to this year's CPHI in Milan.
At the event, the company will display its latest sustainable pharmaceutical packaging and drug delivery solutions, including its novel polypropylene (PP) alternative to PET pill jars.
Berry aims to enhance patient outcomes through its B Circular range of packaging, which can allow companies to meet their sustainability goals.
As well as this, the company has developed a portfolio of products that aim to enhance the accuracy of therapeutic dosing, ease of administration and patient compliance.
Visitors can explore Berry's curated selection of packaging solutions that are designed to meet the needs of patients and healthcare providers in a range of health product categories, with standard and bespoke packaging options available to view.
This includes inhalation, dermal and body care, ophthalmic, nasal, throat and ear sprays, as well as drug delivery devices.
Experts from Berry will also be on site to discuss its fully integrated CDMO services, which provide end-to-end solutions for pharmaceutical companies.
Berry Global Healthcare's VP of Sales, Business Development and R&D, Alan Quemeneur, commented: “CPHI 2024 provides a unique opportunity to showcase how our collaborative approach enables Berry to support our customers in the development of tailored solutions, meeting a significant range of requirements,”
“These include the introduction of circular products with ISCC+ certified recycled plastic (on a mass balance basis) and also our Bmore circular solutions, to help companies meet their sustainability commitments. Furthermore, through our Dose Better initiative Berry works with our consumer healthcare and pharmaceutical customers in the creation of products that improve adherence, administration and safety for an enhanced patient experience.”
